The weekly litigation news digest is live. Subscribe now

Eberhard Karls Universitt Tbingen Medizinische Fakultt competitive analysis

Explore Eberhard Karls Universitt Tbingen Medizinische Fakultt's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jan 1, 2026
Patent NumberPublication DateTitleTotal Oppositions

Get instant alerts of patent oppositions faced by Eberhard Karls Universitt Tbingen Medizinische Fakultt

Dec 4, 2019Permanent Gene Correction By Means Of Nucleotide-Modified Messenger Rna1

Latest PTAB cases involving Eberhard Karls Universitt Tbingen Medizinische Fakultt

Discover the latest PTAB cases involving Eberhard Karls Universitt Tbingen Medizinische Fakultt, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Eberhard Karls Universitt Tbingen Medizinische Fakultt with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 1, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
EBERHARD KARLS UNIVERSITT TBINGEN MEDIZINISCHE FAKULTT - 1 - -
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB33 - - -